S
Sunee Sirivichayakul
Researcher at Chulalongkorn University
Publications - 127
Citations - 3757
Sunee Sirivichayakul is an academic researcher from Chulalongkorn University. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Drug resistance. The author has an hindex of 32, co-authored 121 publications receiving 3196 citations. Previous affiliations of Sunee Sirivichayakul include Vaccine Research Center.
Papers
More filters
Journal ArticleDOI
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration
Rami Kantor,David Katzenstein,Brad Efron,Ana Patricia Carvalho,Brian Wynhoven,Patricia A. Cane,John R. Clarke,Sunee Sirivichayakul,Marcelo A. Soares,Joke Snoeck,Candice Pillay,H Rudich,Rosangela Rodrigues,África Holguín,Koya Ariyoshi,María Belén Bouzas,Pedro Cahn,Wataru Sugiura,Vincent Soriano,Luís Fernando de Macedo Brígido,Z Grossman,Lynn Morris,Anne-Mieke Vandamme,Amilcar Tanuri,Praphan Phanuphak,Jonathan Weber,Deenan Pillay,P. Richard Harrigan,Ricardo Jorge Camacho,Jonathan M. Schapiro,Robert W. Shafer +30 more
TL;DR: Global surveillance and genotypic assessment of drug resistance should focus primarily on the known subtype B drug-resistance mutations.
Journal ArticleDOI
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1 : results of the staccato randomised trial
Jintanat Ananworanich,Angèle Gayet-Ageron,Michelle Le Braz,Wisit Prasithsirikul,Ploenchan Chetchotisakd,Sasisopin Kiertiburanakul,Warangkana Munsakul,Phitsanu Raksakulkarn,Somboon Tansuphasawasdikul,Sunee Sirivichayakul,Matthias Cavassini,Urs Karrer,Daniel Genné,Reto Nüesch,Pietro Vernazza,Enos Bernasconi,Dominic Leduc,Claudette S. Satchell,Sabine Yerly,Luc Perrin,Andrew Hill,Thomas V. Perneger,Praphan Phanuphak,Hansjakob Furrer,David A. Cooper,Kiat Ruxrungtham,Bernard Hirschel +26 more
TL;DR: Drug savings with scheduled treatment interruption were substantial, and no evidence of increased treatment resistance emerged; treatment-related adverse events were more frequent with continuous treatment, but low CD4 counts and minor manifestations of HIV infection were more frequently with scheduledreatment interruption.
Journal ArticleDOI
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
John Gregson,Michele Tang,Nicaise Ndembi,Raph L. Hamers,Soo-Yon Rhee,Vincent C. Marconi,Lameck Diero,Katherine A Brooks,Kristof Theys,Tobias F. Rinke de Wit,Monica B. Arruda,Frederico Garcia,Susana Monge,Huldrych F. Günthard,Christopher J. Hoffmann,Phyllis J. Kanki,N. Kumarasamy,Bernard Kerschberger,Orna Mor,Charlotte Charpentier,Eva Todesco,Casper Rokx,Luuk Gras,Elias K Helvas,Henry Sunpath,Domenico Di Carlo,Antonio Antinori,Massimo Andreoni,Alessandra Latini,Cristina Mussini,Avelin F. Aghokeng,Anders Sönnerborg,Ujjwal Neogi,William J Fessel,Simon Agolory,Chunfu Yang,José Luis Santiago Blanco,James M Juma,Erasmus Smit,Daniel Schmidt,Christine Watera,Juliet Asio,Wilford Kurungi,Anna Tostevin,Tal El-Hay,Nathan Clumeck,Dominique Goedhals,Cloete van Vuuren,Philip A Bester,Caroline A. Sabin,Irene Mukui,Maria Mercedes Santoro,Carlo Federico Perno,Gillian Hunt,Lynn Morris,Ricardo Jorge Camacho,Tulio de Oliveira,Deenan Pillay,Eugene Schulter,Akio Murakami-Ogasawara,Gustavo Reyes-Teran,Karla Romero,Santiago Avila-Rios,Sunee Sirivichayakul,Kiat Ruxrungtham,Suwanna Mekprasan,David Dunn,Pontiano Kaleebu,Elliot Raizes,Rami Kantor,Robert W. Shafer,Ravindra K. Gupta +71 more
TL;DR: A global assessment of drug resistance after virological failure with first-line tenofovir-containing ART, defined as presence of K65R/N or K70E/G/Q mutations in the reverse transcriptase ( RT ) gene.
Journal ArticleDOI
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis
Soo-Yon Rhee,José Luis Santiago Blanco,Michael R. Jordan,Jonathan Taylor,Philippe Lemey,Vici Varghese,Raph L. Hamers,Silvia Bertagnolio,Tobias F. Rinke de Wit,Avelin F. Aghokeng,Jan Albert,Radko Avi,Santiago Ávila-Ríos,Pascal O. Bessong,James Brooks,Charles A. Boucher,Zabrina L. Brumme,Michael P. Busch,Hermann Bussmann,Marie Laure Chaix,Bum Sik Chin,Toni T. D’Aquin,Cillian De Gascun,Anne Derache,Diane Descamps,Alaka Deshpande,Cyrille F. Djoko,Susan H. Eshleman,Hervé Fleury,Pierre Frange,Seiichiro Fujisaki,P. Richard Harrigan,Junko Hattori,África Holguín,Gillian Hunt,Hiroshi Ichimura,Pontiano Kaleebu,David Katzenstein,Sasisopin Kiertiburanakul,Jerome H. Kim,Sung Soon Kim,Yanpeng Li,Irja Lutsar,Lynn Morris,Nicaise Ndembi,Kee Peng Ng,Ramesh S. Paranjape,Martine Peeters,Mario Poljak,Matthew Price,Manon Ragonnet-Cronin,Gustavo Reyes-Terán,Morgane Rolland,Sunee Sirivichayakul,Davey M. Smith,Marcelo A. Soares,Vincent Soriano,Deogratius Ssemwanga,Maja Stanojevic,Mariane A. Stefani,Wataru Sugiura,Somnuek Sungkanuparph,Amilcar Tanuri,Kok Keng Tee,Hong-Ha M. Truong,David A. M. C. van de Vijver,Nicole Vidal,Chunfu Yang,Rongge Yang,Gonzalo Yebra,John P. A. Ioannidis,Anne-Mieke Vandamme,Robert W. Shafer +72 more
TL;DR: Most TDR strains in SSA and SSEA arose independently, suggesting that ARV regimens with a high genetic barrier to resistance combined with improved patient adherence may mitigate TDR increases by reducing the generation of new ARV-resistant strains.
Journal ArticleDOI
Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.
Jintanat Ananworanich,Thanyawee Puthanakit,Piyarat Suntarattiwong,Kulkanya Chokephaibulkit,Stephen J. Kerr,Rémi Fromentin,Wendy Bakeman,Jintana Intasan,Apicha Mahanontharit,Sunee Sirivichayakul,Nicolas Chomont +10 more
TL;DR: Early ART resulted in very low levels of markers of HIV persistence and undetectable HIV-specific immune responses in the majority of HIV-infected children who started ART before 6 months of age.